The impact of centralised care of younger AML patients on
treatment results: a retrospective analysis of real-world data
from a national population-based registry

J 2021

The impact of centralised care of younger AML patients on treatment results: a retrospective analysis of real-world data from a national population-based registry

SEMERAD, Lukas, Zuzana SUSTKOVA, Petr CETKOVSKY, Pavel JINDRA, Zdenek KORISTEK et. al.

Základní údaje

Originální název

The impact of centralised care of younger AML patients on treatment results: a retrospective analysis of real-world data from a national population-based registry

Autoři

Vydání

Acta Oncologica, Taylor and Francis Ltd. 2021, 0284-186X

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30204 Oncology

Stát vydavatele

Velká Británie a Severní Irsko

Utajení

není předmětem státního či obchodního tajemství

Odkazy

URL

Impakt faktor

Impact factor: 4.311

Kód RIV

RIV/00216224:14310/21:00123744

Organizační jednotka

Přírodovědecká fakulta

DOI

http://dx.doi.org/10.1080/0284186X.2021.1917002

UT WoS

000655822500001

EID Scopus

2-s2.0-85106736838

Klíčová slova anglicky

ACUTE MYELOID-LEUKEMIA; STEM-CELL TRANSPLANTATION; HOSPITAL VOLUME; MORTALITY; CHEMOTHERAPY; OUTCOMES

Štítky

rivok

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 27. 1. 2022 11:21, Mgr. Marie Novosadová Šípková, DiS.

Anotace

V originále

The care for younger patients with acute myeloid leukaemia (AML) requires fully equipped medical facilities that have routine experience with the management of this aggressive disorder. Two independent analyses of real-world data from the United States (US) have showed a lower early mortality after an intensive chemotherapy when the patients are treated in high-volume centres or in National Cancer Institution-Designated Cancer Centres (NCI-CC) compared to the treatment in low-volume or in non-NCI-CC centres [1,2].

Citovat

SEMERAD, Lukas, Zuzana SUSTKOVA, Petr CETKOVSKY, Pavel JINDRA, Zdenek KORISTEK, Jan NOVAK, Zdenek RACIL, Tomas SZOTKOWSKI, Barbora WEINBERGEROVA, Pavel ZAK, Zdeněk POSPÍŠIL, Jana BARANOVA a Jiri MAYER. The impact of centralised care of younger AML patients on treatment results: a retrospective analysis of real-world data from a national population-based registry. Acta Oncologica. Taylor and Francis Ltd., 2021, roč. 60, č. 6, s. 818-823. ISSN 0284-186X. Dostupné z: https://dx.doi.org/10.1080/0284186X.2021.1917002.

@article{1821621,
   author = {Semerad, Lukas and Sustkova, Zuzana and Cetkovsky, Petr and Jindra, Pavel and Koristek, Zdenek and Novak, Jan and Racil, Zdenek and Szotkowski, Tomas and Weinbergerova, Barbora and Zak, Pavel and Pospíšil, Zdeněk and Baranova, Jana and Mayer, Jiri},
   article_number = {6},
   doi = {http://dx.doi.org/10.1080/0284186X.2021.1917002},
   keywords = {ACUTE MYELOID-LEUKEMIA; STEM-CELL TRANSPLANTATION; HOSPITAL VOLUME; MORTALITY; CHEMOTHERAPY; OUTCOMES},
   language = {eng},
   issn = {0284-186X},
   journal = {Acta Oncologica},
   title = {The impact of centralised care of younger AML patients on treatment results: a retrospective analysis of real-world data from a national population-based registry},
   url = {https://www.tandfonline.com/doi/full/10.1080/0284186X.2021.1917002},
   volume = {60},
   year = {2021}
}

TY  - JOUR
ID  - 1821621
AU  - Semerad, Lukas - Sustkova, Zuzana - Cetkovsky, Petr - Jindra, Pavel - Koristek, Zdenek - Novak, Jan - Racil, Zdenek - Szotkowski, Tomas - Weinbergerova, Barbora - Zak, Pavel - Pospíšil, Zdeněk - Baranova, Jana - Mayer, Jiri
PY  - 2021
TI  - The impact of centralised care of younger AML patients on treatment results: a retrospective analysis of real-world data from a national population-based registry
JF  - Acta Oncologica
VL  - 60
IS  - 6
SP  - 818-823
EP  - 818-823
PB  - Taylor and Francis Ltd.
SN  - 0284186X
KW  - ACUTE MYELOID-LEUKEMIA
KW  - STEM-CELL TRANSPLANTATION
KW  - HOSPITAL VOLUME
KW  - MORTALITY
KW  - CHEMOTHERAPY
KW  - OUTCOMES
UR  - https://www.tandfonline.com/doi/full/10.1080/0284186X.2021.1917002
N2  - The care for younger patients with acute myeloid leukaemia (AML) requires fully equipped medical facilities that have routine experience with the management of this aggressive disorder. Two independent analyses of real-world data from the United States (US) have showed a lower early mortality after an intensive chemotherapy when the patients are treated in high-volume centres or in National Cancer Institution-Designated Cancer Centres (NCI-CC) compared to the treatment in low-volume or in non-NCI-CC centres [1,2].
ER  -

SEMERAD, Lukas, Zuzana SUSTKOVA, Petr CETKOVSKY, Pavel JINDRA, Zdenek KORISTEK, Jan NOVAK, Zdenek RACIL, Tomas SZOTKOWSKI, Barbora WEINBERGEROVA, Pavel ZAK, Zdeněk POSPÍŠIL, Jana BARANOVA a Jiri MAYER. The impact of centralised care of younger AML patients on treatment results: a retrospective analysis of real-world data from a national population-based registry. \textit{Acta Oncologica}. Taylor and Francis Ltd., 2021, roč.~60, č.~6, s.~818-823. ISSN~0284-186X. Dostupné z: https://dx.doi.org/10.1080/0284186X.2021.1917002.

Přehled o publikaci